Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - CASH & EQUIVALENTS
Cash & Equivalents RARE - Ultragenyx Pharmaceutical Inc.
214 M
LAST VALUE
-16.67%
2 YEAR CAGR
13.49%
5 YEAR CAGR
39.92%
10 YEAR CAGR